Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C42H62O16 |
Molecular Weight | 822.9321 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]7(O[C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@]1([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C5[C@]6([H])C[C@](C)(CC[C@]6(C)CC[C@@]45C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O
InChI
InChIKey=LPLVUJXQOOQHMX-QWBHMCJMSA-N
InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1
Molecular Formula | C42H62O16 |
Molecular Weight | 822.9321 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:00:04 UTC 2023
by
admin
on
Fri Dec 15 16:00:04 UTC 2023
|
Record UNII |
6FO62043WK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
3011 (Number of products:14)
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
||
|
WHO-ATC |
A05BA08
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
||
|
WHO-VATC |
QA05BA08
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000078200
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
26143
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | RxNorm | ||
|
GLYCYRRHIZIN
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
1370586
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
ALTERNATIVE | |||
|
SUB14004MIG
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
6FO62043WK
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
215-785-7
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
6FO62043WK
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
DTXSID8047006
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
167409
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
1359426
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
ALTERNATIVE | |||
|
29807
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
GLYCYRRHIZIN
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
496
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
1325
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
1295888
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
1405-86-3
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
DB13751
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL441687
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
234419
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
m5811
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | Merck Index | ||
|
C1117
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
14982
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
D019695
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY | |||
|
15939
Created by
admin on Fri Dec 15 16:00:04 UTC 2023 , Edited by admin on Fri Dec 15 16:00:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
2.49% of dry weight of contents.
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
DERIVATIVE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
3.27% of dry weight of contents.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
USP
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
The compound did not show significant cytotoxicity against uninfected MDCK cells at 100 uM, but showed inhibitory activity against the H1N1 virus at 100 uM. The compound was also evaluated for anti-HIV activity.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|